Digital Therapeutics for Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a digital cognitive training program to determine its effectiveness in reducing apathy (lack of interest or concern) in individuals with late-life depression. Participants will use a targeted digital tool designed to improve brain connections and boost overall mental function. The trial seeks individuals aged 60 and older who have been diagnosed with depression and experience significant apathy. Those who have been stable on their current antidepressant for at least eight weeks and have access to a computer or tablet with Wi-Fi may find this trial suitable. As an unphased trial, this study offers an opportunity to contribute to innovative research that could enhance mental health treatments for others.
Will I have to stop taking my current medications?
The trial requires that you either be off antidepressants or on a stable dose for at least 8 weeks, and you should not plan to change the dose in the next 5 weeks. You also need to be on a stable dose of other psychotropic medications for at least 8 weeks. If you are taking other psychoactive drugs, you may need to stop if they could affect the study data.
What prior data suggests that this digital cognitive training intervention is safe for treating depression?
Research has shown that digital brain training is generally safe for adults, including those with major depression. One study found that a digital tool called AKL-T03 was safe and helped with cognitive issues related to major depression. Another study demonstrated that a video game-like program improved brain function and mood in middle-aged and older adults with major depressive disorder (MDD). These findings suggest that digital brain training programs are well-tolerated and have not raised any serious safety concerns.12345
Why are researchers excited about this trial?
Researchers are excited about these treatments because they offer a fresh approach to tackling depression by using digital cognitive training. Unlike traditional antidepressants or therapy sessions, the Targeted Cognitive Training Intervention focuses on enhancing specific cognitive functions through digital exercises, potentially providing a more personalized and engaging way to manage depression. This method could complement existing treatments, offering a non-invasive and accessible option that can be tailored to individual needs. By leveraging technology, it might also provide immediate feedback and progress tracking, which could enhance motivation and adherence to the therapy.
What evidence suggests that this trial's treatments could be effective for depression?
Research shows that specific brain exercises can improve thinking skills in people with depression. Several studies have found that these exercises can ease daily life and reduce depression symptoms. In this trial, participants will join one of two treatment arms: the Targeted Cognitive Training Intervention or the General Cognitive Training Intervention. One study found that people improved their ability to remember words after brain training. Another study reported that participants felt less depressed and had more positive thoughts after completing online brain exercises. While results can differ, these findings suggest that targeted brain exercises might help treat lack of motivation and thinking problems in older adults with depression.678910
Who Is on the Research Team?
Lauren Oberlin, PhD
Principal Investigator
AdventHealth
Are You a Good Fit for This Trial?
This trial is for people over 60 with major depressive disorder and significant apathy, but no psychotic features. They must have a certain level of depression severity, be stable on antidepressants or other psychotropic meds for at least 8 weeks, and not plan to change doses soon. Participants need computer access, can follow instructions in English, are able to undergo MRI scans (no metal implants), and aren't at suicide risk or have serious medical/neurological conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 4-week customized digital cognitive training program to target brain function in apathy of late-life depression
Follow-up
Participants are monitored for changes in brain connectivity, apathy severity, and cognitive control performance after treatment
What Are the Treatments Tested in This Trial?
Interventions
- General Cognitive Training Intervention
- Targeted Cognitive Training Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
AdventHealth
Lead Sponsor
Weill Medical College of Cornell University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator